What pharma does to its leaders

In pharma, consensus is the currency of survival. Every decision moves through a committee. The industry selects for thoroughness, rewards control, and produces leaders who cannot tell where the rigour ends and the fortress begins.

The pattern

The patterns pharma builds

The regulatory environment is real. Patient safety demands rigour. Quality is not a platitude — the wrong compound released, the wrong data filed, the wrong process skipped: people get hurt.

But somewhere along the way, the rigour that protects patients becomes the thing that protects identity. The fourth review of a protocol that was ready after the second. The committee cycle that delays a decision nobody wants to own. Quality as both a genuine value and a permanent brake on anything that requires being wrong first.

Two patterns appear again and again. The Protector — who holds everything safe through personal presence, who cannot delegate because not controlling feels like endangering. And the Conductor — the orchestrator who manages through structure, who knows everything the team knows, who attends every meeting because absence means losing grip.

The system is brilliant. It built careers. And it is now the thing preventing the next one.

From the coaching room

Three moments

A senior engineering director. Two decades of being the person with the answers. His team had stopped bringing ideas. I asked what he was protecting. He said quality. Then standards. Then, very quietly: "My place at the table."

His team presented. One member got a question wrong. His hand twitched toward the keyboard. He didn't intervene. The team recovered. "Every time I step back, something whispers: if they fail, it's your fault."

Performance review, third year running: "Strong technical leadership. Needs to develop team." He had every skill. The obstacle was not skill. It was a question about who he is when he's not the one who knows.

What we work on

The specific terrain

Authority without performance

Holding the room without rehearsing the room.

The scientific self

What changes when the data stops being the whole conversation.

Legacy & succession

What of you does the next generation actually need.

Read further

The full pharma article

Two leaders sitting in the same leadership meeting, running entirely different survival strategies, invisible to themselves and each other.

Read the article →

For organisations

Workshops

From Expert to Leader

A workshop for technical leaders navigating the transition from individual expertise to developmental authority. Not a skills programme. An identity programme.

Leadership in Regulated Environments

For leadership teams where the regulatory culture has become indistinguishable from the leadership culture. The line between rigour that protects patients and rigour that protects identity.

Both workshops are available for in-house delivery. Let's talk.

Your industry, your pattern

The pharma pattern brief

A brief on the patterns pharma builds into its strongest leaders — the control, the consensus, and what starts to shift when you can see the fortress.